Unknown

Dataset Information

0

A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route.


ABSTRACT: In a phase I clinical trial, one hundred healthy young adults were randomized to receive two doses 28 days apart of an inactivated, subvirion vaccine containing 15 or 45microg of influenza A/H5N1 hemagglutinin (HA) by the intramuscular (IM) route, or 3 or 9microg of H5 HA by the intradermal(ID) route. Seventy-seven subjects received a third dose. All regimens were safe and well tolerated. Antibody responses after two or three doses were low (

SUBMITTER: Patel SM 

PROVIDER: S-EPMC2913582 | biostudies-literature | 2010 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route.

Patel Shital M SM   Atmar Robert L RL   El Sahly Hana M HM   Cate Thomas R TR   Keitel Wendy A WA  

Vaccine 20091118 17


In a phase I clinical trial, one hundred healthy young adults were randomized to receive two doses 28 days apart of an inactivated, subvirion vaccine containing 15 or 45microg of influenza A/H5N1 hemagglutinin (HA) by the intramuscular (IM) route, or 3 or 9microg of H5 HA by the intradermal(ID) route. Seventy-seven subjects received a third dose. All regimens were safe and well tolerated. Antibody responses after two or three doses were low (<or=20% or <or=38%, respectively) and similar in group  ...[more]

Similar Datasets

| S-EPMC3501693 | biostudies-literature
| S-EPMC10547455 | biostudies-literature
| S-EPMC4324222 | biostudies-literature
| S-EPMC9633716 | biostudies-literature
| S-EPMC6557474 | biostudies-literature
| S-EPMC5405058 | biostudies-literature
| S-EPMC4977438 | biostudies-literature
| S-EPMC4751067 | biostudies-literature
| S-EPMC5054797 | biostudies-literature
| S-EPMC5168719 | biostudies-literature